Old Web
English
Sign In
Acemap
>
authorDetail
>
Matthias Meier
Matthias Meier
Novartis
Medicine
Immunology
Urology
Everolimus
Tacrolimus
4
Papers
20
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
MO148A MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, PARALLEL GROUP, PHASE III STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LNP023 IN PRIMARY IGA NEPHROPATHY PATIENTS
2021
Nephrology Dialysis Transplantation
Vlado Perkovic
Brad H. Rovin
Hong Zhang
Naoki Kashihara
Bart Maes
Dana V. Rizk
Wenyan Wang
Matthias Meier
Dmitrij Kollins
Olympia Papachristofi
Alan Charney
Jonathan Barratt
Show All
Source
Cite
Save
Citations (1)
Three-year outcomes from the CRADLE study in de novo pediatric kidney transplant recipients receiving everolimus with reduced tacrolimus and early steroid withdrawal.
2020
American Journal of Transplantation
Burkhard Tönshoff
H. Tedesco
Robert Ettenger
Martin Christian
Anna Bjerre
Luca Dello Strologo
Stephen D. Marks
Lars Pape
Udaykiran Veldandi
Patricia Lopez
Marc Cousin
Priti Pandey
Matthias Meier
Show All
Source
Cite
Save
Citations (5)
Early conversion of pediatric kidney transplant patients to everolimus with reduced tacrolimus and steroid elimination: Results of a randomized trial
2019
American Journal of Transplantation
Burkhard Tönshoff
Robert B. Ettenger
Luca Dello Strologo
Stephen D. Marks
Lars Pape
Helio Tedesco Silva
Anna Bjerre
Martin Christian
Matthias Meier
El‐Djouher Martzloff
B Rauer
Jennifer Ng
Patricia Lopez
Show All
Source
Cite
Save
Citations (13)
1